We aspire to translate science into survival by developing new immunotherapies
Our mission
We are committed to improving the health of people worldwide with our fundamental research and our work in the area of development of immunotherapies utilizing the full potential of the immune system to fight cancer, infectious diseases and other serious diseases. We believe in scientific rigor, innovation and passion as driving forces. BioNTech was founded by scientists and physicians to translate science into survival by combining fundamental research and operational excellence.
A broad suite of novel technologies
With decades of deep immunology expertise and experience in developing and optimizing mRNA as part of its broad suite of novel technologies, the company is working with the global community to defeat life-threatening and serious diseases such as cancer, COVID-19, malaria and tuberculosis. The first ever approved mRNA vaccine was created in the labs of BioNTech in Mainz, Germany.
The BioNTech Approach
Immune experts and engineers at the core
We, at BioNTech, have a deep legacy of scientific innovation. As pioneers in the field of immunotherapies, we believe that science and innovation can make a difference for humankind. From the very beginning, our focus has always been on exploiting the full potential of the body’s immune system to successfully help address cancer and infectious diseases. Some of our scientists have been conducting fundamental research for decades to understand the immune system and its mechanisms to improve our technologies. We combine powerful new therapeutic mechanisms and a diverse array of biological targets to harness the power of each patient’s immune system. In this way, we aim to develop new treatments and improve the standard of care for various indications.
A fully integrated immunotherapy powerhouse
We remain focused on bringing our broad pipeline of next-generation immunotherapies and vaccines to people around the world to address cancer, infectious diseases, as well as a growing list of other medical conditions. To accomplish this, we continue to be deeply rooted in science and academic research while also having built a fully integrated, global immunotherapy company with cGMP and GMP manufacturing facilities anchored around deep expertise in immunology and complemented by an expanding set of capabilities.
